Memorial Health System Becomes First in Coastal Mississippi to Offer Cutting-Edge Seizure Detection Technology
GULFPORT, Miss. – September 26, 2025 – Memorial Health System is transforming neurological care for critically ill patients with the adoption of the Ceribell System, an FDA-cleared electroencephalography (EEG) device powered by artificial intelligence (AI). The system has been available at Memorial Hospital Gulfport since March 2024, and it was introduced at Memorial Hospital Biloxi on August 4, 2025.
Designed for rapid seizure detection and continuous monitoring, this groundbreaking technology enables hospital teams to quickly make critical treatment decisions and potentially provide better outcomes for patients at risk of non-convulsive seizures.
Non-convulsive seizures present a significant challenge in acute care. These seizures occur without obvious symptoms, making them difficult to detect and often delaying treatment. Like convulsive seizures, without prompt management with anti-seizure medication, non-convulsive seizures can become more difficult to manage, progress to status epilepticus and potentially lead to increased rates of cognitive morbidity and mortality.[1],[2] Millions of ICU and emergency department patients across the U.S. are at risk for these seizures, commonly triggered by conditions such as brain injuries, cardiac arrest, stroke, or sepsis.[3],[4] Similar to stroke, “time is brain” for seizures—prompt diagnosis and intervention are critical as treatment efficacy declines with every hour of delay.2
The Ceribell point-of-care EEG system includes an easy to apply headband, a portable recorder, and intuitive AI-driven software. Setup takes less than 10 minutes, giving clinicians rapid access to EEG data for timely, informed decision-making. A recent retrospective analysis found that compared to conventional EEG, initial assessment with Ceribell was associated with a median reduction of ICU stay by 4 days.[5]
“We are excited to partner with Ceribell to bring this cutting-edge brain diagnostic technology to our patients,” said Memorial Health System Clinical Outcomes and Project Coordinator Samantha Seevers, BSN, RN. “Similar to strokes, with seizures, every minute counts, so early detection is vital in providing the best possible treatment. By incorporating Ceribell into our diagnostic toolkit, we can save critical time and change how we assess and treat our critically ill neurology patients.”
Memorial Health System and Ceribell share a common goal of advancing healthcare through innovative technology. By investing in state-of-the-art technologies such as the Ceribell System, Memorial reaffirms its commitment to delivering the highest quality care to its patients.
This technology is not meant to replace conventional EEG monitoring; it is a complementary solution that enables expanded EEG coverage throughout the hospital. With Ceribell, clinicians can rapidly and more accurately diagnose and manage seizures in the acute care setting, which may reduce the need to transfer patients to other facilities[6],[7] and help us to improve patient outcomes.5
For more information about Memorial’s partnership with Ceribell and its advanced EEG technology, please visit wearememorial.com or www.ceribell.com.
[1] Young, G.B., et al. (1996) Neurology. 47(1):83-89
[2] Lowenstein, D.H., et al. (1993) Neurology, 43(3 Pt 1):483-488
[3] Laccheo, I., et al. (2015) Neurocrit Care. 22(2):202-211
[4] Herman, S.T., et al. (2015) J Clin Neurophysiol. 32(2):87-99
[5] Desai, M., et al. (2024) Neurocrit Care
[6] Madill, E.S., et al. (2022) Epileptic Disorders. 24(3):507-516
[7] Ward, J., et al. (2023) Front. Digit. Health. 5(1)
###
ABOUT MEMORIAL HEALTH SYSTEM
Memorial Health System has been serving the Mississippi Gulf Coast since 1946. Located in Gulfport, Mississippi, Memorial is a not-for-profit public community hospital organized under the laws of the state of Mississippi and is jointly owned by the City of Gulfport and Harrison County. Memorial Health System includes three hospitals (Gulfport, Biloxi, and Stone County) licensed for 481 beds, a state-designated Level II Trauma Center, two nursing centers, outpatient surgery centers, satellite outpatient diagnostic and rehabilitation centers, and more than 100 Memorial Physician Clinics. Memorial offers several of the region’s most comprehensive clinical programs and medical specialties unique to the area, including a Level III Neonatal ICU and Mississippi’s first nationally certified Primary Stroke Center. Memorial is accredited by The Joint Commission, a Baby-Friendly Designated hospital, and is a member of the Mississippi Healthcare Collaborative. Visit wearememorial.com to learn more.
ABOUT THE CERIBELL SYSTEM
The Ceribell system is a novel, point-of-care EEG platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with a sophisticated AI-powered algorithm, the Ceribell system enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell system is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. The Ceribell system received two FDA Breakthrough Device Designations in 2022. In 2023, the latest generation of Ceribell’s AI algorithm (Clarity™) made it the first and only EEG system to receive 510(k) clearance for diagnosing electrographic status epilepticus. Subsequently, the Clarity algorithm received a New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS). The Ceribell System has been adopted by more than 550 hospitals and has been used to diagnose and monitor over 200,000 patients.